Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4 + T cells

Blood

Volumn 112, Issue 6, 2008, Pages 2381-2389

  Fourmentraux Neves, Emmanuelle ^a   Jalil, Abdelali ^a   Da Rocha, Sylvie ^a   Pichon, Christophe ^a   Chouaib, Salem ^a   Bismuth, Georges ^b   Caignard, Anne ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; HLA C ANTIGEN; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; MONOCLONAL ANTIBODY; PROTEIN KINASE C THETA; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; T LYMPHOCYTE RECEPTOR; TYROSINE; ISOENZYME; LYMPHOCYTE ANTIGEN RECEPTOR; PRKCQ PROTEIN, HUMAN; PROTEIN KINASE C; PTPN11 PROTEIN, HUMAN; PTPN6 PROTEIN, HUMAN;

ANTIGEN RECOGNITION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; BIOSYNTHESIS; CELL CULTURE; GENETICS; IMMUNOLOGY; METABOLISM;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HUMANS; INTERLEUKIN-2; ISOENZYMES; PROTEIN KINASE C; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, KIR2DL1; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 55249094151     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-12-127779     Document Type: Article

References (42)

1. Vivier E, Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past actors of the future. Nat Rev Immunol. 2004;4:190-198.
2. Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225-274.
3. Barford D, Neel BG. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2. Structure. 1998:6: 249-254.
4. Burshtyn DN, Scharenberg AM, Wagtmann N, et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity. 1996:4: 77-85.
5. Olcese L, Lang P, Vely F, et al. Human and mouse killer-cell inhibitory receptors recruit PTP1 C and PTP1 D protein tyrosine phosphatases. J Immunol. 1996:156:4531-4534.
6. Bruhns P, Marchetti P, Fridman WH, Vivier E, Daeron M. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors. J Immunol. 1999;162:3168-3175.
7. Barrow AD, Trowsdale J. You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling. Eur J Immunol. 2006: 36:1646-1653.
8. Agazie YM, Hayman MJ. Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling. Mol Cell Biol. 2003;23:7875-7886.
9. Zhang SQ, Yang W, Kontaridis Ml, etal. Shp2 regulates SRG family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell. 2004;13:341-355.
10. Battistini L, Borsellino G, Sawicki G, et al. Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors. J Immunol. 1997:159:3723-3730.
11. Nakajima H, Tomiyama H, Takiguchi M. Inhibition of gamma delta T cell recognition by receptors for MHC class I molecules. J Immunol. 1995;155: 4139-4142.
12. Ferrini S, Cambiaggi A, Meazza R. et al. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol. 1994:24:2294-2298.
13. Mingari MC, Schiavetti F, Ponte M, et al. Human CD8+ T lymphocyte subsets that express HLA class l-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci U S A. 1996;93:12433-12438.
14. Ugolini S, Arpin C, Anfossi N, et al. Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells. Nat Immunol. 2001;2:430-435.
15. Young NT, Uhrberg M, Phillips JH, Lanier LL, Parham P. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J Immunol. 2001;166:3933-3941.
16. Mingari MC, Moretta A, Moretta L. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunol Today. 1998:19:153-157.
17. Guerra N, Michel F, Gati A, et al. Engagement of the inhibitory receptor CD158a interrupts TGR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction. Blood. 2002;100:2874-2881.
18. van Bergen J. Thompson A, van der Slik A, Ottenhoff TH, Gussekloo J, Koning F Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol. 2004; 173:6719-6726.
19. Nakajima T, Goek O, Zhang X, et al. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res. 2003;93:106-113.
20. Namekawa T, Snyder MR, Yen JH, et al. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null Tcells clonally expanded in rheumatoid arthritis. J Immunol. 2000; 165:1138-1145.
21. Yen JH, Moore BE, Nakajima T, et al. Major histocompatibility complex class l-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med. 2001;193:1159-1167.
22. Bagot M, Moretta A, Sivori S, et al. CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. Blood. 2001;97:1388-1391.
23. Marie-Cardine A, Huet D, Ortonne N, etal. Killer cell Ig-like receptors CD 158a and CD 158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sezary syndrome. Blood. 2007; 109:5064-5065.
24. Dietrich J, Cella M, Golonna M. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization. J Immunol. 2001;166:2514-2521.
25. Phillips JH, Gumperz JE, Parham P, Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science. 1995;268:403-405.
26. D'AndreaA, Chang C, Phillips JH, Lanier LL. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. J Exp Med. 1996;184:789-794.
27. Bakker AB, Phillips JH, Figdor CG, Lanier LL. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigenspecific CTL. J Immunol. 1998;160:5239-5245.
28. Anfossi N, Pascal V, Vivier E, Ugolini S. Biology of T memory type 1 cells. Immunol Rev. 2001; 181:269-278.
29. Snyder MR, Nakajima T, Leibson PJ, Weyand CM, Goronzy JJ. Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms. J Immunol. 2004;173:3725-3731.
30. Henel G, Singh K, Cui D, et al. Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors. Blood. 2006:107:4449-4457.
31. Chwae YJ, Chang MJ, Park SM, et al. Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells. J Immunol. 2002; 169:3726-3735.
32. Chemnitz JM, Parry RV, Nichols KE, June CH, Riley JL. SHP-1 and SHP-2 associate with immunoreceptortyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents Tcell activation. J Immunol. 2004;173:945-954.
33. Yusa S, CatinaTL, Campbell KS. SHP-1-and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NKcells. J Immunol. 2002;168:5047-5057.
34. Mustelin T, Tasken K. Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem J. 2003;371:15-27.
35. Ostman A, Hellberg C, Bohmer FD. Proteintyrosine phosphatases and cancer. Nat Rev Cancer. 2006;6:307-320.
36. Shi ZQ, Lu W, Feng GS. The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases. J Biol Chem. 1998;273:4904-4908.
37. Bjorbaek C, Buchholz RM, Davis SM, et al. Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem. 2001;276:4747-4755.
38. Park JH, Levitt L. Overexpression of mitogenactivated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of AP1, NF-AT, and NF-KB. Blood. 1993;82:2470-2477.
39. Whitehurst CE, GeppertTD. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in Tcells. J Immunol. 1996;156:1020-1029.
40. Sun Z, Arendt CW, Ellmeier W, et al. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature. 2000;404:402-407.
41. 2+ mobilization and NFAT cell activation in primary mouse T cells. J Exp Med. 2003;197:1525-1535.
42. Monks CR, Kupfer H, Tamir I, Barlow A, Kupfer A. Selective modulation of protein kinase C-theta during T-cell activation. Nature. 1997;385:83-86.